Jump to ContentJump to Main Navigation
Show Summary Details

Roth, Christian

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Cohen, Pinhas / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Feihong / Mericq, Veronica / Toppari, Jorma

Editorial Board Member: Battelino, Tadej / Buyukgebiz, Atilla / Cassorla, Fernando / Chrousos, George P. / Cutfield, Wayne / Fideleff, Hugo L. / Hershkovitz, Eli / Hiort, Olaf / LaFranchi, Stephen H. / Lanes M. D., Roberto / Mohn, Angelika / Root, Allen W. / Rosenfeld, Ron G. / Werther, George / Zadik, Zvi

IMPACT FACTOR 2015: 0.912

SCImago Journal Rank (SJR) 2015: 0.493
Source Normalized Impact per Paper (SNIP) 2015: 0.600
Impact per Publication (IPP) 2015: 0.955

See all formats and pricing


Select Volume and Issue


Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study

Stanislava Koloušková1 / Daniela Zemková1 / Jana Bartošová1 / Veronika Skalická1 / Zdeněk Šumník1 / Věra Vávrová1 / 1

1Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital Prague-Motol, V Uvalu 84, CZ-150 06 Praha 5, Czech Republic

Corresponding author: Prof. Jan Lebl, MD, PhD, Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague, V Uvalu 84, CZ-150 06 Praha 5, Czech Republic Phone: +420 224 432 001, Fax: +420 224 432 020

Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 24, Issue 7-8, Pages 449–454, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem.2011.050, July 2011

Publication History

Published Online:


Cystic fibrosis related diabetes (CFRD) is an insulinopenic condition. We aimed to detect insulinopenia early and to evaluate the impact of low dose insulin on nutritional status and forced expiratory volume in first second (FEV1). Out of 142 cystic fibrosis patients (CFpts) older than 10 years, 28 with abnormal oral glucose tolerance test in spite of normal fasting glycemia were found to have decreased first phase insulin release and started low dose insulin therapy (median age 15.4 years). Sex and age matched CFpts with normal glucose tolerance (NGT) were observed for comparison. Whereas nutritional status improved following 3 years of insulin administration, FEV1 stabilized in insulin-treated insulinopenic subjects (73.8±4.3% vs. 73.5±4.4%), but decreased in the parallel group with NGT who remained without insulin treatment (71.1±3.8% vs. 61.0±4.0%; p=0.001). We conclude that low dose insulin improves nutritional status and stabilizes pulmonary functions. Regular estimation of stimulated insulin secretion in CFpts may allow optimizing treatment.

Keywords: cystic fibrosis; cystic fibrosis related diabetes; insulinopenia; insulin treatment; pulmonary function tests

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Mariana Zorrón Mei Hsia Pu, Flávia Corrêa Christensen‐Adad, Aline Cristina Gonçalves, Walter José Minicucci, José Dirceu Ribeiro, and Antonio Fernando Ribeiro
Revista Paulista de Pediatria, 2016
An Jacobs, Francois Vermeulen, Kris de Boeck, Kristina Casteels, and Marijke Proesmans
Open Journal of Pathology, 2016, Volume 06, Number 01, Page 32
Oren Ledder, Wolfram Haller, Richard TL Couper, Peter Lewindon, and Mark Oliver
Journal of Gastroenterology and Hepatology, 2014, Volume 29, Number 12, Page 1954
Antoinette Moran, Kubendran Pillay, Dorothy J Becker, and Carlo L Acerini
Pediatric Diabetes, 2014, Volume 15, Number S20, Page 65
Adèle Coriati, Belinda Elisha, Sandrine Virassamynaik, Maude Phaneuf, Sophie Ziai, Marie-Soleil Gauthier, and Rémi Rabasa-Lhoret
Applied Physiology, Nutrition, and Metabolism, 2013, Volume 38, Number 12, Page 1254

Comments (0)

Please log in or register to comment.